TAKEDA ONCOLOGY - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86476462
Serial Number
86476462
Registration Number
5438550
Word Mark
TAKEDA ONCOLOGY
Status
700 - Registered
Status Date
2018-04-03
Filing Date
2014-12-10
Registration Number
5438550
Registration Date
2018-04-03
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261709 - Curved line(s), band(s) or bar(s).
Published for Opposition Date
2015-06-30
Attorney Name
Karl M. Zielaznicki, Esq.
Law Office Assigned Location Code
M40
Employee Name
FRYE, KIMBERLY
Statements
Indication of Colors claimed
The color(s) red and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"ONCOLOGY"
Description of Mark
The mark consists of the word "TAKEDA" in stylized red lettering, appearing inside of two red intersecting arcs, the lower arc with a straight line on the bottom and the higher arc being thicker in size and with two sides extending over the lower arc; below the straight line of the lower arc appears the word "ONCOLOGY" in black stylized lettering. The white in the mark represents background or transparency and is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
Goods and Services
Providing live and on-line classes and seminars in the field of cancer treatment
Goods and Services
Pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services
Goods and Services
Medical and diagnostic services, namely, medical diagnostic testing and monitoring services; medical testing for diagnostic or treatment purposes; medical testing in the nature of diagnostic testing, prognostic testing, gene and protein testing, and identifying physiological characteristics and hereditary risk factors, all for the purpose of diagnosing disease or predicting one's propensity for disease in order to prevent disease and establish individual disease prevention programs, or provide medical prognosis; medical services, namely, establishing disease treatment plans and disease management programs based on gene and protein expression and/or activity; medical services, namely, evaluating clinical trial progress and drug monitoring for patient treatment and disease management purposes, including tracking of a patient's health progress via computer
Classification Information
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2014-12-15
Primary Code
041
First Use Anywhere Date
2015-04-01
First Use In Commerce Date
2015-04-01
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2014-12-15
Primary Code
042
First Use Anywhere Date
2015-04-01
First Use In Commerce Date
2015-04-01
Current Trademark Owners
Party Name
Takeda Pharmaceutical Company Limited
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Takeda Pharmaceutical Company Limited
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Takeda Pharmaceutical Company Limited
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Takeda Pharmaceutical Company Limited
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Karl M. Zielaznicki, Esq.
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration0768955
Prior Registration0769053
Prior Registration4307191
Trademark Events
Event DateEvent Description
2014-12-13NEW APPLICATION ENTERED IN TRAM
2014-12-15NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2014-12-16NOTICE OF DESIGN SEARCH CODE E-MAILED
2015-03-24ASSIGNED TO EXAMINER
2015-03-31NON-FINAL ACTION WRITTEN
2015-03-31NON-FINAL ACTION E-MAILED
2015-03-31NOTIFICATION OF NON-FINAL ACTION E-MAILED
2015-04-08TEAS RESPONSE TO OFFICE ACTION RECEIVED
2015-04-08CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-04-09TEAS/EMAIL CORRESPONDENCE ENTERED
2015-04-29APPROVED FOR PUB - PRINCIPAL REGISTER
2015-05-26ASSIGNED TO LIE
2015-05-26LAW OFFICE PUBLICATION REVIEW COMPLETED
2015-06-10NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2015-06-30PUBLISHED FOR OPPOSITION
2015-06-30OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2015-08-25NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2016-01-21TEAS EXTENSION RECEIVED
2016-01-21EXTENSION 1 FILED
2016-01-21EXTENSION 1 GRANTED
2016-01-23NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2016-08-08TEAS EXTENSION RECEIVED
2016-08-31CASE ASSIGNED TO INTENT TO USE PARALEGAL
2016-08-08EXTENSION 2 FILED
2016-09-02EXTENSION 2 GRANTED
2016-09-03NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-02-27TEAS EXTENSION RECEIVED
2017-02-27EXTENSION 3 FILED
2017-02-27EXTENSION 3 GRANTED
2017-03-01NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-05-11TEAS CHANGE OF CORRESPONDENCE RECEIVED
2017-07-11TEAS STATEMENT OF USE RECEIVED
2017-07-11USE AMENDMENT FILED
2017-08-05STATEMENT OF USE PROCESSING COMPLETE
2017-08-26SU - NON-FINAL ACTION - WRITTEN
2017-08-26NON-FINAL ACTION E-MAILED
2017-08-26NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-01-17TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-01-17TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-01-19CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-01-19TEAS/EMAIL CORRESPONDENCE ENTERED
2018-01-23SU - FINAL REFUSAL - WRITTEN
2018-01-23FINAL REFUSAL E-MAILED
2018-01-23NOTIFICATION OF FINAL REFUSAL EMAILED
2018-02-20TEAS REQUEST FOR RECONSIDERATION RECEIVED
2018-02-22CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-02-22TEAS/EMAIL CORRESPONDENCE ENTERED
2018-02-28ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2018-03-01NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2018-04-03REGISTERED-PRINCIPAL REGISTER
2018-06-22TEAS CHANGE OF CORRESPONDENCE RECEIVED
2019-08-29TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-07-01TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-07-01TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-07-01ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-07-01TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
2020-07-01TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-07-01APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-07-02REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED